Inhibitor Therapeutics (INTI) Shares Issued (2012 - 2025)
Inhibitor Therapeutics' (INTI) quarterly Shares Issued came in at $3.1 million in Q4 2025, up 7.5% YoY from $2.9 million in Q4 2024, and little changed on a QoQ basis from $3.1 million in Q3 2025.
Inhibitor Therapeutics (INTI) Shares Issued (2012 - 2025) Analysis & Trends
Inhibitor Therapeutics (INTI) has 11 years of Shares Issued data on file, last reported at $3.1 million in Q4 2025.
- Quarterly Shares Issued rose 7.5% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 7.5% YoY) and the FY2025 annual result came in at $3.1 million, up 7.5% from the prior year.
- Shares Issued was little changed at $3.1 million in Q4 2025, from $3.1 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $13.3 million in Q4 2021 to a low of $2.6 million in Q4 2022.
- A 5-year average of $3.6 million and a median of $2.9 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued slumped 80.71% — and 2024, when it gained 11.26%.
- Tracing INTI's Shares Issued over 5 years: stood at $13.3 million in 2021, then tumbled by 80.71% to $2.6 million in 2022, then changed by 0.0% to $2.6 million in 2023, then advanced by 11.26% to $2.9 million in 2024, then increased by 7.5% to $3.1 million in 2025.
- The last three Shares Issued figures came in at $3.1 million (Q4 2025), $3.1 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | - |
| 10 | Inhibitor Therapeutics | 15.64 Mn | 15.64 Mn | - | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.08 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 2.87 Mn |
| Mar 31, 2025 | 2.87 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | 2.58 Mn |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 2.58 Mn |
| Sep 30, 2023 | 2.58 Mn |